Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL744 (BHV-0223, Exservan, NSC-753433, NSC-759823, Rilutek, Riluzol, Riluzole, Riluzole zentiva, RP 54274, RP-54274, Teglutik, Tiglutik, Tiglutik kit) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
Kv11.1/HERG in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL240] [GtoPdb: 572] [UniProtKB: Q12809] | ||||||||
GtoPdb | Inhibition of currents via human Kv11.1 (hERG) channels expressed in HEK293 cells in whole-cell patch-clamp experiments. | - | 4.3 | pIC50 | 50000 | nM | IC50 | Mol Pharmacol (2009) 75: 281-95 [PMID:18955585] |
ChEMBL | Displacement of Tracer Red from human ERG by fluorescence polarization assay | B | 4.6 | pIC50 | >25000 | nM | IC50 | J Med Chem (2019) 62: 3989-4012 [PMID:30908048] |
NET/Norepinephrine transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL222] [GtoPdb: 926] [UniProtKB: P23975] | ||||||||
ChEMBL | DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) | B | 5.76 | pKi | 1718 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) | B | 5.76 | pIC50 | 1733 | nM | IC50 | DrugMatrix in vitro pharmacology data |
Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364] | ||||||||
ChEMBL | Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay | F | 5.1 | pIC50 | 7943.28 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
Pteridine reductase 1 in Leishmania major (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6194] [UniProtKB: Q01782] | ||||||||
ChEMBL | Inhibition of Leishmania major PTR1 by Lineweaver-Burk analysis | B | 5.4 | pKi | 4000 | nM | Ki | J Med Chem (2011) 54: 211-221 [PMID:21126022] |
ChEMBL | Inhibition of Leishmania major pteridine reductase 1 using di-hydrobiopterine as substrate in presence of NADPH | B | 4.03 | pIC50 | 94100 | nM | IC50 | J Med Chem (2019) 62: 3989-4012 [PMID:30908048] |
ChEMBL | Inhibition of Leishmania major PTR1 | B | 4.3 | pIC50 | 50000 | nM | IC50 | J Med Chem (2011) 54: 211-221 [PMID:21126022] |
Nav1.2/Sodium channel protein type II alpha subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4187] [GtoPdb: 579] [UniProtKB: Q99250] | ||||||||
ChEMBL | Blockade of synaptosomal sodium channels, inhibition of [14C]guanidinium ion flux into CHO cells expressing Type II sodium channel | F | 5.66 | pIC50 | 2200 | nM | IC50 | Bioorg Med Chem Lett (1995) 5: 2259-2262 |
Nav1.2/Sodium channel protein type II alpha subunit in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3399] [GtoPdb: 579] [UniProtKB: P04775] | ||||||||
ChEMBL | Sodium channel block, determined by % block of [14C]guanidinium flux in CHO line expressing rat type IIA sodium channels derived from rat brain | F | 5.33 | pIC50 | 4730 | nM | IC50 | J Med Chem (1998) 41: 3298-3302 [PMID:9703475] |
Nav1.4/Sodium channel protein type IV alpha subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2072] [GtoPdb: 581] [UniProtKB: P35499] | ||||||||
ChEMBL | Inhibition of human Nav 1.4 expressed in HEK293T cells assessed as tonic block at 0.1 Hz by whole cell patch clamp assay | B | 4.2 | pIC50 | 63000 | nM | IC50 | ACS Med Chem Lett (2023) 14: 999-1008 [PMID:37465302] |
ChEMBL | Inhibition of human Nav 1.4 expressed in HEK293T cells assessed as phasic block at 10 Hz by whole cell patch clamp assay | B | 4.29 | pIC50 | 51000 | nM | IC50 | ACS Med Chem Lett (2023) 14: 999-1008 [PMID:37465302] |
Nav1.7/Sodium channel protein type IX alpha subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4296] [GtoPdb: 584] [UniProtKB: Q15858] | ||||||||
ChEMBL | Inhibition of human Nav 1.7 expressed in HEK293T cells assessed as tonic block at 0.1 Hz by whole cell patch clamp assay | B | 4.25 | pIC50 | 56000 | nM | IC50 | ACS Med Chem Lett (2023) 14: 999-1008 [PMID:37465302] |
ChEMBL | Inhibition of human Nav 1.7 expressed in HEK293T cells assessed as phasic block at 10 Hz by whole cell patch clamp assay | B | 4.39 | pIC50 | 41000 | nM | IC50 | ACS Med Chem Lett (2023) 14: 999-1008 [PMID:37465302] |
KCa2.1 in Human [GtoPdb: 381] [UniProtKB: Q92952] | ||||||||
GtoPdb | - | - | 4.68 | pEC50 | 21000 | nM | EC50 | Mol Pharmacol (2009) 75: 281-95 [PMID:18955585] |
KCa2.2 in Rat [GtoPdb: 382] [UniProtKB: P70604] | ||||||||
GtoPdb | - | - | 4.89 | pEC50 | 12800 | nM | EC50 | Mol Pharmacol (2009) 75: 281-95 [PMID:18955585] |
KCa2.3 in Human [GtoPdb: 383] [UniProtKB: Q9UGI6] | ||||||||
GtoPdb | - | - | 4.9 | pEC50 | 12500 | nM | EC50 | Mol Pharmacol (2009) 75: 281-95 [PMID:18955585] |
KCa3.1 in Human [GtoPdb: 384] [UniProtKB: O15554] | ||||||||
GtoPdb | - | - | 5.7 | pIC50 | - | - | - | Mol Pharmacol (2009) 75: 281-95 [PMID:18955585] |
TRPC5 in Human [GtoPdb: 490] [UniProtKB: Q9UL62] | ||||||||
GtoPdb | - | - | 5.04 | pEC50 | 9200 | nM | EC50 | Br J Pharmacol (2014) 171: 158-70 [PMID:24117252] |
Kv4.2 in Rat [GtoPdb: 553] [UniProtKB: Q63881] | ||||||||
GtoPdb | Inhibition of currents via rat Kv4.2 channels expressed in LTK cells in whole-cell patch-clamp experiments. | - | 3.89 | pIC50 | 130000 | nM | IC50 | Mol Pharmacol (2009) 75: 281-95 [PMID:18955585] |
Kv4.3 in Rat [GtoPdb: 554] [UniProtKB: Q62897] | ||||||||
GtoPdb | - | - | 3.9 | pIC50 | - | - | - | J Pharmacol Exp Ther (2006) 319: 323-31 [PMID:16815868] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]